Drivers Roche Diagnostics Port Devices

  



Non-Roche Point of Care devices (open connectivity) In order to meet the demands of the healthcare providers, regulatory bodies and accreditation guidelines, the cobas IT 1000 application is built on an infrastructure that provides the flexibility to address the needs of healthcare facilities and allows the management of test results, operators. Global Diabetes Care Devices Market 2017-2021 About Diabetes Care Devices Diabetes care devices are used to monitor and control the level of blood glucose. It includes SMBG meters, SMBG test strips, insulin pumps, insulin syringes. These are used to administer appropriate amount of insulin to the patient. Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years.

  1. Drivers Roche Diagnostics Port Devices Inc
  2. Drivers Roche Diagnostics Port Devices For Sale
  3. Drivers Roche Diagnostics Port Devices Online
  4. Drivers Roche Diagnostics Port Devices List

Drivers Roche Diagnostics Port Devices Inc

Our emphasis on extraordinary customer service — delivered by talented, dedicated people — uniquely positions Roche Diagnostics to lead the way in research and development of creative solutions for unmet medical needs. The prominent players in glucose monitoring devices market include Life scan Inc., Becton, Dickinson and Co., Terumo Corporation, Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, ARKRAY Inc., Novo Nordisk A/S, Medtronic, Abbott Laboratories, Bayer AG, Ypsomed AG, and Sanofi. Blood Glucose Monitoring Devices Market Segmentation.

  • Model / Serial
    Technavio’s analysts forecast the global diabetes care devices market to grow at a CAGR of 10.72% during the period 2017-2021.
    Covered in this report
    The report covers the present scenario and the growth prospects of the global diabetes care devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of the four diabetes care products, namely SMBG meters, SMBG test strips, insulin pumps, and insulin strips.
    The market is divided into the following segments based on geography:

    • Americas
    • APAC
    • EMEA
    Technavio's report, Global Diabetes Care Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
    Key vendors
    • Abbott Laboratories
    • Becton Dickinson
    • LifeScan
    • Roche Diagnostics
    Other prominent vendors
    • AgaMatrix
    • Animas
    • Beurer
    • Bioptik Technology
    • DarioHealth
    • DexCom
    • GlySens
    • Integrity Applications
    • Medisana
    • MediWise
    • Menarini Diagnostics
    • Nemaura
    • Nova Biomedical
    • Senseonics
    • TaiDoc Technology
    DriversMarket driver
    • Friendly reimbursement policies
    • For a full, detailed list, view our report

    Drivers Roche Diagnostics Port Devices For Sale

    Market challenge
    • High cost of devices
    • For a full, detailed list, view our report

    Drivers Roche Diagnostics Port Devices Online

    Market trend
    • Rising preference for specialty clinics over hospitals
    • For a full, detailed list, view our report
    Key questions answered in this report
    • What will the market size be in 2021 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?

    Drivers Roche Diagnostics Port Devices List


    Press Release
    Technavio Announces the Publication of its Research Report – Global Diabetes Care Devices Market 2017-2021
    Technavio recognizes the following companies as the key players in the global diabetes care devices market: Abbott Laboratories, Becton Dickinson, LifeScan, and Roche Diagnostics
    Other Prominent Vendors in the market are: AgaMatrix, Animas, Beurer, Bioptik Technology, DarioHealth, DexCom, GlySens, Integrity Applications, Medisana, MediWise, Menarini Diagnostics, Nemaura, Nova Biomedical, Senseonics, and TaiDoc Technology.
    Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Rising preference for specialty clinics over hospitals. In earlier times, the treatment for diabetes was provided in hospitals where an endocrinologist or a dietician guided patient in the management of Type 1 diabetes. Though fruitful results were achieved during the process, there were some issues that made patients look for alternatives. The reasons were long waiting times leading to crowding, limited visiting slots, high consultation fees, and availability of devices stock. As a result, patients had no choice but to revisit hospitals repeatedly to get the check-up done. This looked favorable from the view of hospitals, but not for the patients.”
    According to the report, one of the major drivers for this market is Friendly reimbursement policies. Diabetes care devices are mostly expensive and can act as an economic burden on individuals, as these diseases require day-to-day medications. Globally, countries are framing reimbursement policies for diabetes care devices. For example, developed countries such as the US provide coverage for these products under an insurance scheme that is likely to create more demand for diabetes care devices as more people will be able to afford diabetes care devices. Over the past few years, there has been a favorable upgrade in Medicare (the official website of the US Government for medical health related information) reimbursement in the US.
    Further, the report states that one of the major factors hindering the growth of this market is High cost of devices. The increasing global diabetic population has led to a rise in the healthcare expenditure on medication as well as insulin delivery devices, especially for Type 1 diabetic population. There are various devices in the market that deliver insulin to patients and monitor blood glucose levels through various routes of administration. The price of these products highly varies, and patients buy products based on the affordability. For instance, the high cost of blood glucose test strips is a major challenge hindering the growth of the global diabetes care devices market. Blood-glucose level monitoring with the use of invasive devices is both painful and expensive process. The pain is due to the lancet pricking the fingertip for blood needed for testing. The expenditure is due to the use of consumable test strips, on which the drop of blood needs to be placed before being inserting into the reader.
    Companies Mentioned
    Abbott Laboratories, Becton Dickinson, LifeScan, and Roche Diagnostics, AgaMatrix, Animas, Beurer, Bioptik Technology, DarioHealth, DexCom, GlySens, Integrity Applications, Medisana, MediWise, Menarini Diagnostics, Nemaura, Nova Biomedical, Senseonics, and TaiDoc Technology.